SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Subhashie Wijemanne, Laura J.C. Wu, Joseph Jankovic, Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome, Movement Disorders, 2014, 29, 1
  2. 2
    Andreas Hartmann, Advances in the Neurochemistry and Neuropharmacology of Tourette Syndrome, 2013,

    CrossRef

  3. 3
    Veit Roessner, Kerstin J. Plessen, Aribert Rothenberger, Andrea G. Ludolph, Renata Rizzo, Liselotte Skov, Gerd Strand, Jeremy S. Stern, Cristiano Termine, Pieter J. Hoekstra, European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment, European Child & Adolescent Psychiatry, 2011, 20, 4, 173

    CrossRef

  4. 4
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  5. 5
    David R.P. Guay, Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders, The American Journal of Geriatric Pharmacotherapy, 2010, 8, 4, 331

    CrossRef

  6. 6
    Nicte I. Mejia, Joseph Jankovic, Metoclopramide-induced tardive dyskinesia in an infant, Movement Disorders, 2005, 20, 1
  7. 7
    Drug-Induced Movement Disorders, 2004,

    CrossRef

  8. 8
    Karen Anderson, William Weiner, Handbook of Tourette's Syndrome and Related Tic and Behavioral Disorders, Second Edition, 2004,

    CrossRef

  9. 9
    Drug-Induced Movement Disorders, 2004,

    CrossRef

  10. 10
    Kirsten R Müller-Vahl, The treatment of Tourette’s syndrome: current opinions, Expert Opinion on Pharmacotherapy, 2002, 3, 7, 899

    CrossRef

  11. 11
    David Marcus, Roger Kurlan, Tics and its disorders, Neurologic Clinics, 2001, 19, 3, 735

    CrossRef

  12. 12
    Adityanjee, Yekeen A Aderibigbe, V.Chowdary Jampala, Thomas Mathews, The current status of tardive dystonia, Biological Psychiatry, 1999, 45, 6, 715

    CrossRef

  13. 13
    MICHEL MENNESSON, BETH A. KLINK, AUGUSTE H. FORTIN, Case Study: Worsening Tourette's Disorder or Withdrawal Dystonia?, Journal of the American Academy of Child & Adolescent Psychiatry, 1998, 37, 7, 785

    CrossRef

  14. 14
    Katie Kompliti, Christopher G. Goetz, Hyperkinetic movement disorders misdiagnosed as tics in gilles de la tourette syndrome, Movement Disorders, 1998, 13, 3
  15. 15
    Roger Kurlan, TREATMENT OF TICS, Neurologic Clinics, 1997, 15, 2, 403

    CrossRef

  16. 16
    Jaime Kulisevsky, Marcelo L. Berthier, Asunción Avila, Longitudinal evolution of prefrontal leucotomy in Tourett's syndrome, Movement Disorders, 1995, 10, 3
  17. 17
    Joseph Jankovic, Botulinum toxin in the treatment of dystonic tics, Movement Disorders, 1994, 9, 3